Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients

Abstract

SARS-CoV-2 specific T-cellular and antibody responses persisted for 6 months post confirmed infection. In previously infected patients, re-exposure or vaccination will boost long-term immunity, possibly providing protection against re-infection with variant viruses.